Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma

Saved in:
Bibliographic Details
Published inEuropean journal of cancer (1990) Vol. 61; p. S200
Main Authors Gieffers, C, Merz, C, Sykora, J, Kunz, C, Thiemann, M, Wiestler, B, Wick, W, Fricke, H
Format Journal Article
LanguageEnglish
Published 01.07.2016
Subjects
Hematology, Oncology and Palliative Medicine
Online AccessGet full text

Cover

More Information
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(16)61707-0